---
title: "COCP.US (COCP.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/COCP.US/news.md"
symbol: "COCP.US"
name: "COCP.US"
parent: "https://longbridge.com/zh-HK/quote/COCP.US.md"
datetime: "2026-03-14T07:56:22.791Z"
locales:
  - [en](https://longbridge.com/en/quote/COCP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/COCP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/COCP.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/COCP.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/COCP.US/news.md)


# COCP.US (COCP.US) — 相關新聞

### [Natco rallies 5%, nears 52-week high; what's driving pharma stock?](https://longbridge.com/zh-HK/news/278491008.md)
*2026-03-09T20:32:36.000Z*
> Natco Pharma shares rose 5% to ₹1,047.65, nearing a 52-week high, driven by the launch of Pomalidomide Capsules in the U

### [Cocrystal Initiates Phase 1b Norovirus Antiviral Challenge Study](https://longbridge.com/zh-HK/news/278398168.md)
*2026-03-09T13:02:01.000Z*
> Cocrystal Pharma has initiated a Phase 1b norovirus antiviral challenge study at Emory University, dosing the first subj

### [Noble Financial Sticks to Their Buy Rating for Cocrystal Pharma (COCP)](https://longbridge.com/zh-HK/news/276629179.md)
*2026-02-23T17:15:35.000Z*
> Noble Financial analyst Robert LeBoyer has maintained a Buy rating for Cocrystal Pharma (COCP) with a price target of $6

### [Cocrystal Pharma Director and 10% Owner Phillip Frost Reports Acquisition of Common Shares](https://longbridge.com/zh-HK/news/275362440.md)
*2026-02-09T21:10:37.000Z*
### [Cocrystal Pharma Grants Stock Options to Directors and Executives Under New Equity Plan](https://longbridge.com/zh-HK/news/272746342.md)
*2026-01-15T21:11:41.000Z*
### [Insider Makes Bold Move on Cocrystal Pharma Shares](https://longbridge.com/zh-HK/news/271379540.md)
*2026-01-03T02:02:32.000Z*
> Cocrystal Pharma (COCP) saw significant insider activity on January 2, 2026, as Director Phillip Frost purchased 50,000 

### [Director and 10% Owner Phillip Frost Reports Acquisition of Cocrystal Pharma Inc. Common Shares](https://longbridge.com/zh-HK/news/271360705.md)
*2026-01-02T21:11:04.000Z*
### [Director and 10% Owner Phillip Frost Reports Acquisition of Cocrystal Pharma Common Shares](https://longbridge.com/zh-HK/news/271244957.md)
*2025-12-31T21:10:52.000Z*